Recently discovered contamination of 2 rotavirus vaccines by pig viruses is unlikely to pose a human health threat, according to the US Food and Drug Administration (FDA). The agency recommended in May that physicians resume use of one vaccine, Rotarix, and continue use of the other vaccine, RotaTeq.
On March 22, the FDA had recommended that physicians suspend the use of Rotarix after the agency learned that academic researchers made the unexpected finding that the vaccine contained DNA from porcine circovirus 1 (PCV1), a virus that is common in US swine but not associated with illness in pigs or humans (Victoria JG et al. J Virol. 2010;84:6033-6040). This finding was confirmed by scientists from the FDA and the vaccine's maker, GlaxoSmithKline.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Graphic Jump Location
Scientists have detected DNA from porcine circovirus 1 and 2 in rotavirus vaccines.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 7
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.